Skip to content
HealthTech Series A Founded 2016

SimBioSys

Provider of AI-based decision-making and cancer diagnosis tool for healthcare professionals

📍 Chicago, United States · Clinical Labs IT

Funding snapshot

Last roundSeries A
Amount$5M
Date20 December 2024

About

Provider of AI-based decision-making and cancer diagnosis tool for healthcare professionals. The company has developed TumorScope a digital software that uses AI-based technology and supercomputing to model the behavior of cancer in humans for diagnosis. It has tools for tumor visual on from patients MRI, PET, or other radiology scans. TumorScope software provides predictions of the tumor pre-treatment for lung cancer, prostate cancer, and breast cancer.

Latest news

No articles yet.

Raising like SimBioSys?

Analyze your pitch deck before your next raise.

Analyze My Deck →